DLA Piper has advised ResApp Health Limited on the deal. ResApp Health Limited (ResApp) announced its A$180 million cash acquisition by Pfizer Australia Holdings Pty Limited…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Laura Testa
…
This content is for Standard 1 Year members only. LoginJoin Now